Short Interest in CapsoVision, Inc. (NASDAQ:CV) Expands By 171.0%

CapsoVision, Inc. (NASDAQ:CV) saw a large increase in short interest in December. As of December 15th, there was short interest totaling 215,141 shares, an increase of 171.0% from the November 30th total of 79,381 shares. Based on an average trading volume of 607,389 shares, the short-interest ratio is currently 0.4 days. Currently, 0.5% of the company’s stock are sold short. Currently, 0.5% of the company’s stock are sold short. Based on an average trading volume of 607,389 shares, the short-interest ratio is currently 0.4 days.

CapsoVision Stock Down 6.3%

Shares of CV opened at $13.01 on Friday. CapsoVision has a 12 month low of $3.43 and a 12 month high of $15.37. The firm’s fifty day simple moving average is $7.35.

CapsoVision (NASDAQ:CV) last announced its earnings results on Thursday, November 13th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.03). The company had revenue of $3.54 million during the quarter.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on CV shares. Zacks Research raised shares of CapsoVision to a “hold” rating in a research report on Wednesday, November 5th. Weiss Ratings reissued a “sell (e)” rating on shares of CapsoVision in a research note on Monday, December 22nd. Benchmark restated a “speculative buy” rating on shares of CapsoVision in a report on Friday, November 14th. Finally, Roth Capital set a $7.00 price target on CapsoVision in a report on Tuesday, November 4th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $6.00.

Institutional Trading of CapsoVision

A hedge fund recently bought a new stake in CapsoVision stock. New York State Common Retirement Fund purchased a new stake in shares of CapsoVision, Inc. (NASDAQ:CV) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 7,114 shares of the company’s stock, valued at approximately $34,000.

CapsoVision Company Profile

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.